Downregulation of miR-98 was shown to lead to the upregulation of cyclin D2, which is involved in the vascular complications of type 2 diabetes mellitus [58,59], and upregulation of miR-98 prevented cardiac hypertrophy via inhibition of cyclin D2 [60]. The gene discussed is CCND2; the disease is cardiac hypertrophy.